Prioritizing disease-causing microbes based on random walking on the heterogeneous network.

As we all know, the microbiota show remarkable variability within individuals. At the same time, those microorganisms living in the human body play a very important role in our health and disease, so the identification of the relationships between microbes and diseases will contribute to better understanding of microbes interactions, mechanism of functions. However, the microbial data which are obtained through the related technical sequencing is too much, but the known associations between the diseases and microbes are very less. In bioinformatics, many researchers choose the network topology analysis to solve these problems. Inspired by this idea, we proposed a new method for prioritization of candidate microbes to predict potential disease-microbe association. First of all, we connected the disease network and microbe network based on the known disease-microbe relationships information to construct a heterogeneous network, then we extended the random walk to the heterogeneous network, and used leave-one-out cross-validation and ROC curve to evaluate the method. In conclusion, the algorithm could be effective to disclose some potential associations between diseases and microbes that cannot be found by microbe network or disease network only. Furthermore, we studied three representative diseases, Type 2 diabetes, Asthma and Psoriasis, and finally presented the potential microbes associated with these diseases by ranking candidate disease-causing microbes, respectively. We confirmed that the discovery of the new associations will be a good clinical solution for disease mechanism understanding, diagnosis and therapy.

[1]  Lionel Fry,et al.  Comparison of bacterial microbiota in skin biopsies from normal and psoriatic skin , 2011, Archives of Dermatological Research.

[2]  Jeremy K. Nicholson,et al.  Gut microbiota: a potential new territory for drug targeting , 2008, Nature Reviews Drug Discovery.

[3]  K. Chiller,et al.  Skin microflora and bacterial infections of the skin. , 2001, The journal of investigative dermatology. Symposium proceedings.

[4]  P. Robinson,et al.  Walking the interactome for prioritization of candidate disease genes. , 2008, American journal of human genetics.

[5]  Frank Klawonn,et al.  High-Resolution Taxonomic Profiling of the Subgingival Microbiome for Biomarker Discovery and Periodontitis Diagnosis , 2014, Applied and Environmental Microbiology.

[6]  Lior Pachter,et al.  Disordered Microbial Communities in Asthmatic Airways , 2010, PloS one.

[7]  A. Barabasi,et al.  Human symptoms–disease network , 2014, Nature Communications.

[8]  A. Russo,et al.  Cancer and the microbiome: potential applications as new tumor biomarker , 2015, Expert review of anticancer therapy.

[9]  Young Juhn,et al.  Assessment of the association between pediatric asthma and Streptococcus pyogenes upper respiratory infection. , 2009, Allergy and asthma proceedings.

[10]  Xiaochen Bo,et al.  mmnet: An R Package for Metagenomics Systems Biology Analysis , 2015, BioMed research international.

[11]  J. Raes,et al.  Microbial interactions: from networks to models , 2012, Nature Reviews Microbiology.

[12]  S. Mazmanian,et al.  An Immunomodulatory Molecule of Symbiotic Bacteria Directs Maturation of the Host Immune System , 2005, Cell.

[13]  José Luís Oliveira,et al.  Computational methodology for predicting the landscape of the human-microbial interactome region level influence , 2015, J. Bioinform. Comput. Biol..

[14]  S. Sørensen,et al.  Gut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic Adults , 2010, PloS one.

[15]  Steven R Feldman,et al.  Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. , 2008, Journal of the American Academy of Dermatology.

[16]  F. Bäckhed,et al.  The gut microbiota — masters of host development and physiology , 2013, Nature Reviews Microbiology.

[17]  Niranjan Nagarajan,et al.  @MInter: automated text-mining of microbial interactions , 2016, Bioinform..

[18]  Roded Sharan,et al.  The large-scale organization of the bacterial network of ecological co-occurrence interactions , 2010, Nucleic acids research.

[19]  Katherine S. Pollard,et al.  MetaQuery: a web server for rapid annotation and quantitative analysis of specific genes in the human gut microbiome , 2015, Bioinform..

[20]  Jagdish Chandra Patra,et al.  Genome-wide inferring gene-phenotype relationship by walking on the heterogeneous network , 2010, Bioinform..

[21]  KARL PEARSON,et al.  The Problem of the Random Walk , 1905, Nature.

[22]  S. Mazmanian,et al.  Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota , 2010, Proceedings of the National Academy of Sciences.

[23]  Sejal Saglani,et al.  Lung microbiota promotes tolerance to allergens in neonates via PD-L1 , 2014, Nature Medicine.

[24]  P. Gibson,et al.  Streptococcus pneumoniae infection suppresses allergic airways disease by inducing regulatory T-cells , 2010, European Respiratory Journal.

[25]  Tobias Kollmann,et al.  Early infancy microbial and metabolic alterations affect risk of childhood asthma , 2015, Science Translational Medicine.

[26]  S. Sutton,et al.  Implications of the human microbiome on pharmaceutical microbiology , 2013 .

[27]  Martin J. Blaser,et al.  Substantial Alterations of the Cutaneous Bacterial Biota in Psoriatic Lesions , 2008, PloS one.

[28]  J. Kreth,et al.  Streptococcal Antagonism in Oral Biofilms: Streptococcus sanguinis and Streptococcus gordonii Interference with Streptococcus mutans , 2008, Journal of bacteriology.